Cargando…

Meta-Analysis of Microarray Data Identifies GAS6 Expression as an Independent Predictor of Poor Survival in Ovarian Cancer

Seeking new biomarkers for epithelial ovarian cancer, the fifth most common cause of death from all cancers in women and the leading cause of death from gynaecological malignancies, we performed a meta-analysis of three independent studies and compared the results in regard to clinicopathological pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buehler, Michelle, Tse, Brian, Leboucq, Alix, Jacob, Francis, Caduff, Rosmarie, Fink, Daniel, Goldstein, Darlene R., Heinzelmann-Schwarz, Viola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710590/ https://www.ncbi.nlm.nih.gov/pubmed/23878800 http://dx.doi.org/10.1155/2013/238284

Ejemplares similares

Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients
por: Jacob, Francis, et al.
Publicado: (2012)

Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies
por: Pochechueva, Tatiana, et al.
Publicado: (2011)

Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study
por: Samartzis, Nicolas, et al.
Publicado: (2012)

Uterine Tumors Resembling Ovarian Sex Cord Tumors – Treatment, recurrence, pregnancy and brief review
por: Schraag, Sabrina M., et al.
Publicado: (2017)

Expression pattern of class I histone deacetylases in vulvar intraepithelial neoplasia and vulvar cancer: a tissue microarray study
por: Samartzis, Nicolas, et al.
Publicado: (2011)

Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
por: Henry, Claire, et al.
Publicado: (2015)

ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer
por: Montavon Sartorius, Céline, et al.
Publicado: (2018)

Reliable in vitro studies require appropriate ovarian cancer cell lines
por: Jacob, Francis, et al.
Publicado: (2014)

Outcome in serous ovarian cancer is not associated with LATS expression
por: Montavon, Céline, et al.
Publicado: (2019)

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
por: Popple, A, et al.
Publicado: (2012)

Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers
por: Sartorius, Céline Montavon, et al.
Publicado: (2018)

Exposure to escalating olaparib does not induce acquired resistance to PARPi and to other chemotherapeutic compounds in ovarian cancer cell lines
por: Fedier, André, et al.
Publicado: (2022)

Patient-derived and artificial ascites have minor effects on MeT-5A mesothelial cells and do not facilitate ovarian cancer cell adhesion
por: Estermann, Manuela, et al.
Publicado: (2020)

High‐grade serous peritoneal cancer follows a high stromal response signature and shows worse outcome than ovarian cancer
por: Jacob, Francis, et al.
Publicado: (2020)

Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells
por: Jacob, Francis, et al.
Publicado: (2014)

Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients
por: Pochechueva, Tatiana, et al.
Publicado: (2016)

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma
por: Yang, Guo-Fen, et al.
Publicado: (2010)

Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients
por: Pochechueva, Tatiana, et al.
Publicado: (2017)

Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer
por: Dondi, Arthur, et al.
Publicado: (2023)

L1CAM is not a reliable predictor for lymph node metastases in endometrial cancer, but L1CAM positive patients benefit from radiotherapy
por: Zeiter, Deborah, et al.
Publicado: (2021)

Tumor-Associated Glycans and Their Role in Gynecological Cancers: Accelerating Translational Research by Novel High-Throughput Approaches
por: Pochechueva, Tatiana, et al.
Publicado: (2012)

Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer
por: Coelho, Ricardo, et al.
Publicado: (2022)

L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population
por: Terraneo, Nastassja, et al.
Publicado: (2020)

ADAM12 is an independent predictor of poor prognosis in liver cancer
por: Du, Shuangqiu, et al.
Publicado: (2022)

Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer
por: Liu, Shui, et al.
Publicado: (2021)

Selecting control genes for RT-QPCR using public microarray data
por: Popovici, Vlad, et al.
Publicado: (2009)

Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol
por: Katapodi, Maria C, et al.
Publicado: (2017)

How does colpocleisis for pelvic organ prolapse in older women affect quality of life, body image, and sexuality? A critical review of the literature
por: Felder, Laetitia, et al.
Publicado: (2022)

The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells
por: Ford, Caroline E., et al.
Publicado: (2013)

Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment
por: Vetter, Marcus, et al.
Publicado: (2022)

High expression of VCAN is an independent predictor of poor prognosis in gastric cancer
por: Li, Wenfei, et al.
Publicado: (2020)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
por: Gooden, M J M, et al.
Publicado: (2014)

High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer
por: Qin, Lianzhi, et al.
Publicado: (2017)

Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma
por: Anugraham, Merrina, et al.
Publicado: (2017)

Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2011)

Application of independent component analysis to microarrays
por: Lee, Su-In, et al.
Publicado: (2003)

Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
por: Zhang, Peng, et al.
Publicado: (2019)

Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma
por: Ebert, Lisa M., et al.
Publicado: (2021)

Aberrant ARMCX1 Expression Is an Independent Predictor of Poor Prognosis in Gastric Cancer
por: Xie, Aosi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5bcq4vmjqhj1jvp7vu0cu4etnt